-
Trump's devoted 'human printer' in media glare
-
Germany, France, UN condemn far-right Israeli minister's 'inhumane' Gaza remarks
-
Top seed Zverev bundled out by Paul in rain-hit Cincinnati upset
-
Prince Harry and Meghan moving back to UK: British press
-
WADA pledges vigilance on Russian athletes ahead of 2028 Olympics
-
Lee, Baena guide Atletico to opening Liga win over Malaga
-
NASA satellite rescue mission fails
-
Ecuador intel chief, five Americans killed in Kenya helicopter crash
-
Cobolli halts Jodar to reach Cincinnati quarter-finals
-
Robinson and Tongue share match ball after dismissing Pakistan
-
As election looms, Netanyahu puts Turkey in Israel's crosshairs
-
Israel army admits firing on car in death of five-year-old Hind Rajab
-
McIlroy questions LIV stars 'value' as talk of PGA return builds
-
Honduras places 80% of country on El Nino drought alert
-
'Breakthrough' mRNA cancer drug curbs melanoma in large trial
-
Some of Meta's safety tools were 'designed to fail': witness
-
Many US Fed policymakers back interest rate hikes if inflation stays high
-
PSG Ligue 1 opener moved over state of Parc des Princes pitch
-
Robinson and Tongue star as Pakistan collapse in England opener
-
UK PM launches bid to help homeless, donating part of his wages
-
All Blacks must get 'everything right' to beat Springboks, says legend Fitzpatrick
-
Golden Shoe winner Kane hopes for Ballon d'Or after 'best season ever'
-
Robinson and Tongue star as Pakistan all out for 171 in England opener
-
Kyiv's ex-defence chief makes risky bet by venturing into electoral grounds
-
Lake Zurich sees water level hit record low amid drought
-
Coventry have survival inspiration says Lampard
-
Merck and Moderna's tailored cancer drug curbs melanoma recurrence in trial
-
Reijnders leaves Man City for Saudi's Al Qadsiah
-
Referees chief Webb wants clamp-down on Premier League set-piece grappling
-
Trump says will meet North Korea's Kim later this year
-
Robinson makes history as Pakistan collapse against England
-
Stocks waver, dollar drops as US Treasury moves to lower bond yields
-
Alvarez can win back Atletico fans in two games: club chief
-
France recalls rare disease drug Tavneos after deaths
-
Oldest human brain cells grown in lab 'recorded passage of time'
-
Arsenal agree to sign Villa defender Konsa: reports
-
7,300 excess deaths and counting in France's historically hot summer
-
Evacuation orders lifted in Belgian wildfire zone
-
Ukraine MPs approve new defence minister after divisive reshuffle
-
UK media skewered for 'hounding' black academic
-
North Korea leader's sister says 'unaware' of reported Kim-Trump communication
-
More than 7,300 excess deaths in France's historically hot summer so far
-
Russia, Ukraine exchange 103 captured soldiers each
-
US socialists score shock Florida win as Trump picks stumble
-
Sainz signs new contract with F1 team Williams
-
Iran warns Gulf countries against helping US after UAE cuts trade ties
-
Playing at Real Madrid 'not for everyone': Bernardo Silva
-
Senior FIFA official withdraws support from embattled Infantino
-
As election nears, Israelis fear polarisation could spark violence
-
Lawson replaces injured Hadjar for Red Bull at Dutch GP
Philips turns in a profit but China, tariffs weigh
Dutch medical device maker Philips reported a net profit for the first time in three quarters Tuesday despite weak sales in China but warned of "intensified" uncertainties due to tariffs.
Net profits came in at 72 million euros ($82 million), compared to a net loss of 998 million euros in the same quarter last year and 333 million euros in the fourth quarter of 2024.
"It's an encouraging start to the year," the firm's chief executive Roy Jakobs told reporters.
Jakobs predicted that the second half of the year would be stronger for the firm than the first half.
"In an uncertain macro environment that has intensified due to the potential impact of tariffs, we are focused on what we can control," he added.
The company estimated a hit of between 250-300 million euros from tariffs over the year.
Philips maintained its forecast for between one and three percent growth in sales for 2025, but slightly cut its projection for earnings before special items (EBITA).
The firm pointed to a two-percent growth in orders globally, with China again proving a drag. Without China, the order growth would have been four percent, Philips said.
However, global sales were down two percent compared to the same quarter last year due to a "double-digit decline" in China, the firm said.
Philips has previous warned that a slowing Chinese economy was hurting consumer demand for products and the government's anti-corruption drive was hitting procurement.
Once famous for making lightbulbs and televisions among other products, Amsterdam-based Philips in recent years has sold off subsidiaries to focus on medical care technology.
Since 2021, the company has been battling a series of crises over its DreamStation machines for sleep apnoea, a disorder in which breathing stops and starts during sleep.
Millions of devices were recalled over concerns that users were at risk of inhaling pieces of noise-cancelling foams and fears it could potentially cause cancer.
In April 2024, it announced it had reached a $1.1 billion deal to settle US lawsuits over the faulty machines.
P.Staeheli--VB